South Rampart Pharma, Inc.
PrivateLast Round
Series A
Apr 10, 2025
Total Funding Raised
$2.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
South Rampart Pharma, Inc. is a clinical-stage biopharmaceutical company that develops novel, non-opioid small molecule therapeutics designed to treat pain while avoiding the organ toxicity and addiction risks associated with current analgesics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
South Rampart Pharma, Inc. Comparables
Compare South Rampart Pharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latigo Biotherapeutics | 87% | |
| Akelos Inc. | 84% | |
| Eli Lilly and Company | 81% |
South Rampart Pharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 10, 2025 | ||||
| Grant | Sep 21, 2023 | ||||
| Grant | Sep 29, 2020 |
South Rampart Pharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gulf South Angels | Series A |
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 232% MoM, reaching 1.4K.
- Jun 20, 2026
Monthly visitors grew 147% MoM.
South Rampart Pharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about South Rampart Pharma, Inc.'s valuation, stock price, and market status.
Is South Rampart Pharma, Inc. a public or private company?
South Rampart Pharma, Inc. is a private company.
What is the current stock price of South Rampart Pharma, Inc.?
South Rampart Pharma, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is South Rampart Pharma, Inc. worth (valuation)?
Valuation information for South Rampart Pharma, Inc. is not publicly available.
Can I buy South Rampart Pharma, Inc. stock?
South Rampart Pharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was South Rampart Pharma, Inc.'s last funding round?
South Rampart Pharma, Inc.'s most recent funding round was Series A on April 10, 2025.
Who are the main investors in South Rampart Pharma, Inc.?
Key investors in South Rampart Pharma, Inc. include Gulf South Angels, NIH RADx.
Will South Rampart Pharma, Inc. IPO soon?
No public IPO plans have been announced for South Rampart Pharma, Inc..
How can I track South Rampart Pharma, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor South Rampart Pharma, Inc.'s secondary market activity and sign up for updates.